A comprehensive guide by a leading Medical Oncologist — covering symptoms, stages, the latest treatment options, and how to seek the right care.
What Is Breast Cancer?
Breast cancer is the uncontrolled growth of abnormal cells in the breast tissue. It is the most frequently diagnosed cancer in women in India, and with the right specialist care, it is increasingly treatable.
Breast cancer begins when cells in the breast mutate and grow out of control, forming a tumour. Although it is predominantly diagnosed in women, men can also develop breast cancer. The good news is that advances in oncology — especially precision medicine and targeted therapies — have dramatically improved survival rates when the disease is caught early.
As a Medical Oncologist in Hyderabad, Dr. Harshavardhan Annadanam leads a multidisciplinary team that crafts personalised treatment plans for every patient, based on tumour biology, genetic profile, and overall health.
Why Early Awareness Matters
Breast Cancer in India — Key Numbers
1 in 28
Indian women develop breast cancer in their lifetime
#1
Most common cancer among Indian women
90%
+5-year survival rate when detected at Stage
~30%
Cases are diagnosed in women under 40 in India
🟢 Early Detection Saves Lives
Women diagnosed at an early stage (Stage I or II) have a survival rate above 90%. Regular self-examination and annual mammography screening are critical, especially after age 40 or if you carry a family history of breast cancer.
Oncology Essentials
Types of Breast Cancer
Breast cancer is not a single disease — it is a diverse group of conditions, each requiring a tailored approach. Dr. Harshavardhan Annadanam specialises in all major subtypes:
Invasive Ductal Carcinoma (IDC)
The most common type (~80% of cases), originating in the milk ducts and spreading to surrounding breast tissue
Invasive Lobular Carcinoma (ILC)
Starts in the milk-producing glands (lobules) and can spread to other parts of the body. Often harder to detect on imaging.
Triple-Negative Breast Cancer (TNBC)
Lacks three common receptors, making it more aggressive. Treated with chemotherapy, immunotherapy, and PARP inhibitors.
HER2-Positive Breast Cancer
Overexpresses the HER2 protein, making it fast-growing but highly responsive to targeted therapies like Trastuzumab
Hormone Receptor-Positive (ER+/PR+)
Fuelled by oestrogen or progesterone. Treated effectively with hormonal therapy (Tamoxifen, Aromatase Inhibitors).
Inflammatory Breast Cancer (IBC)
A rare, aggressive form presenting as skin redness and swelling rather than a lump. Requires urgent multimodal treatmen
Know the Warning Signs
Symptoms of Breast Cancer
Many breast cancers are found through routine screening before any symptoms appear. However, when signs do develop, recognising them early is vital:
- Painless lump or thickening in the breast or underarm
- Change in breast size, shape, or appearance
- Skin dimpling or orange-peel texture (peau d’orange)
- Nipple inversion or changes in nipple direction
- Nipple discharge (especially blood-stained)
- Persistent breast pain in one area
- Skin redness, warmth, or swelling over the breast
- Rash or crusting around the nipple (Paget’s disease)
⚠️ When to See an Oncologist Immediately
If you notice any of the above symptoms, do not delay. Early medical evaluation by a qualified oncologist like Dr. Harshavardhan Annadanam in Hyderabad can make a life-saving difference.
Cancer Staging
Stages of Breast Cancer Explained
Staging helps determine how far the cancer has spread and guides the treatment approach. The TNM (Tumour, Node, Metastasis) system is internationally used:
Stage 0
DCIS
Non-Invasive / Pre-Cancer
Abnormal cells are confined to the milk ducts. No spread to surrounding tissue. Nearly 100% survival rate with treatment.
Stage I
Early
Cancer is small and contained within the breast. 5-year survival rate exceeds 95%. Excellent outcomes with surgery ± radiation.
Stage II
Regional
Tumour is 2–5 cm or has reached nearby lymph nodes. 5-year survival rate ~80–90%. Typically treated with surgery, chemotherapy, and targeted therapy.
Stage III
Advanced
Significant Lymph Node or Chest Wall Involvement
Cancer has spread extensively to regional lymph nodes. Requires aggressive combination treatment. 5-year survival ~40–70%.
Stage IV
Metastatic
Cancer has spread to other organs. Focus is on life-prolonging treatment and quality of life. Modern therapies significantly extend survival.
Investigations & Screening
How Is Breast Cancer Diagnosed?
Accurate diagnosis is the foundation of effective treatment. Dr. Harshavardhan Annadanam uses a comprehensive diagnostic workup:
Clinical Breast Examination
A thorough physical examination of the breast and regional lymph nodes is the starting point for any evaluation.
Imaging Studies
Mammography remains the gold standard for screening. Breast Ultrasound is used for younger women with denser breast tissue. Breast MRI is recommended for high-risk individuals, pre-surgical planning, and to assess response to neoadjuvant chemotherapy.
Biopsy & Pathology
A tissue biopsy — via core needle, fine-needle aspiration (FNAC), or vacuum-assisted biopsy — is the only definitive way to confirm cancer. The sample is tested for hormone receptors (ER, PR), HER2 status, Ki-67 index, and grade.
Molecular & Genetic Testing
Tests like Oncotype DX, BRCA1/BRCA2 gene analysis, and comprehensive genomic profiling help personalise chemotherapy decisions and assess hereditary risk.
Staging Investigations
PET-CT scans, bone scans, chest X-ray, liver ultrasound, and blood tests (CBC, LFT, tumour markers) are used to assess disease extent.
Personalised Oncology
Breast Cancer Treatment Options in Hyderabad
Dr. Harshavardhan Annadanam offers world-class, evidence-based breast cancer treatment in Hyderabad. Every plan is personalised — no two patients receive identical care.
🔪 Surgery — Lumpectomy & Mastectomy
Breast-conserving lumpectomy (removing only the tumour) or mastectomy (removing the entire breast). Sentinel lymph node biopsy guides the need for axillary clearance. Reconstruction options are discussed with patients upfront.
💊 Chemotherapy
Uses powerful drugs to kill cancer cells. May be given before surgery (neoadjuvant — to shrink tumours) or after (adjuvant — to eliminate residual disease). Regimens are tailored to tumour subtype and patient fitness.
🎯 Targeted Therapy
Precision medicines that attack specific cancer cell mechanisms. HER2-positive cancers respond to Trastuzumab (Herceptin), Pertuzumab, and T-DM1. CDK4/6 inhibitors (Palbociclib, Ribociclib) are standard for HR+ metastatic disease.
🌡 Radiation Therapy
High-energy beams that destroy remaining cancer cells after surgery. Essential after breast-conserving surgery and in certain Stage III cases. Modern techniques minimise heart exposure.
💊 Hormonal Therapy (Endocrine Therapy)
For ER+/PR+ cancers — Tamoxifen (pre-menopausal), Aromatase Inhibitors (Letrozole, Anastrozole, Exemestane) for post-menopausal women. Used for 5–10 years to prevent recurrence.
🛡 Immunotherapy
Pembrolizumab (Keytruda) is now approved for early and metastatic triple-negative breast cancer. It unleashes the immune system to attack cancer cells, significantly improving survival in eligible patients.
🧬 PARP Inhibitors & Novel Agents
Olaparib and Talazoparib are used for BRCA-mutated HER2-negative metastatic breast cancer. Antibody-drug conjugates (Sacituzumab Govitecan, T-DXd) have revolutionised the treatment of previously difficult-to-treat subtypes.
Every case treated by Dr. Harshavardhan Annadanam is discussed in a Multidisciplinary Tumour Board (MDT) — involving medical oncologists, surgical oncologists, radiation oncologists, radiologists, and pathologists — to ensure the best possible outcome for each patient.
Who Is at Risk?
Breast Cancer Risk Factors
Understanding your risk helps guide screening decisions. Several modifiable and non-modifiable factors influence breast cancer risk:
- Female gender (risk is 100× higher in women)
- Age above 40 years
- Family history of breast or ovarian cancer
- BRCA1 / BRCA2 gene mutations
- Dense breast tissue
- Previous breast cancer or DCIS
- Previous radiation to the chest (e.g. for lymphoma)
- Early menstruation (before age 12)
- Late menopause (after age 55)
- Hormone replacement therapy (long-term)
- Oral contraceptive use (slight increase)
- Nulliparity (never having given birth)
- Alcohol consumption
- Obesity / excess weight (post-menopause)
- Sedentary lifestyle / physical inactivity
- Postmenopausal hormone therapy
Proactive Health
Prevention & Early Detection
While not all breast cancers are preventable, the following measures can significantly reduce risk and ensure early detection:
Monthly Breast Self-Examination (BSE)
Every woman above 20 years should perform a monthly breast self-examination, ideally 7–10 days after the start of a menstrual period. Knowing what is normal for your body helps detect any changes early.
Annual Clinical Breast Examination
A yearly examination by a doctor is recommended from age 25. Women with a family history or genetic risk may require surveillance starting earlier.
Mammography Screening
The Indian Society of Medical and Paediatric Oncology (ISMPO) recommends annual mammography from age 40 for average-risk women. High-risk women may need MRI-based screening in addition.
Lifestyle Modifications
Maintaining a healthy weight, exercising at least 150 minutes per week, limiting alcohol, breastfeeding when possible, and avoiding unnecessary hormone therapy can meaningfully lower breast cancer risk.
Genetic Counselling & BRCA Testing
Women with a first-degree relative (mother, sister, daughter) diagnosed with breast or ovarian cancer should consider genetic counselling and BRCA testing. High-risk individuals may benefit from risk-reducing medications (chemoprevention) or surgical options.